Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon MetabolismAamod S. Dekhne, Larry H. Matherly|Molecular Pharmacology|2019Cited by 36
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian CancerAdrianne Wallace-Povirk, Larry H. Matherly|Molecular Cancer Therapeutics|2024Cited by 13